FRASCA, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 2.763
EU - Europa 992
AS - Asia 405
AF - Africa 24
SA - Sud America 23
OC - Oceania 3
Totale 4.210
Nazione #
US - Stati Uniti d'America 2.745
IT - Italia 444
SE - Svezia 165
SG - Singapore 142
IN - India 121
CN - Cina 95
UA - Ucraina 71
FI - Finlandia 69
DE - Germania 60
BG - Bulgaria 32
FR - Francia 26
NL - Olanda 23
GB - Regno Unito 18
CH - Svizzera 16
HK - Hong Kong 16
AR - Argentina 15
IE - Irlanda 14
CA - Canada 13
TG - Togo 13
RO - Romania 10
DK - Danimarca 9
TR - Turchia 8
ES - Italia 6
PH - Filippine 6
SC - Seychelles 6
AT - Austria 5
BE - Belgio 5
KR - Corea 5
RU - Federazione Russa 5
MK - Macedonia 4
AU - Australia 3
BR - Brasile 3
BZ - Belize 3
JP - Giappone 3
PE - Perù 3
ZA - Sudafrica 3
CO - Colombia 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
MX - Messico 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
UG - Uganda 2
BY - Bielorussia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
LU - Lussemburgo 1
MD - Moldavia 1
PK - Pakistan 1
PL - Polonia 1
VN - Vietnam 1
Totale 4.210
Città #
Fairfield 457
Ashburn 215
Woodbridge 200
Chandler 193
Seattle 179
Houston 174
Wilmington 151
Cambridge 145
Rome 129
Dearborn 113
Singapore 101
Ann Arbor 98
San Paolo di Civitate 73
Princeton 61
Lawrence 51
Plano 49
Beijing 39
San Diego 34
Sofia 30
Millbury 28
Helsinki 27
New York 25
Milan 22
Boston 21
Westminster 21
Andover 18
Santa Clara 17
Hong Kong 16
San Jose 16
Federal 13
Lomé 13
Norwalk 12
Toronto 12
Boardman 11
San Mateo 11
Rotterdam 10
Bremen 9
Dublin 9
Phoenix 9
Fremont 8
Hefei 8
Jacksonville 8
Kunming 8
Bari 7
Chicago 6
Dallas 6
Redwood City 6
Turin 6
Zhengzhou 6
Amsterdam 5
Brussels 5
Mahé 5
Paris 5
Southend 5
Vienna 5
Buk-gu 4
Falls Church 4
Florence 4
Kingston 4
Messina 4
Nanjing 4
Romainville 4
Stockholm 4
Trecastagni 4
Venezia 4
Belize City 3
Bodrum 3
Bühl 3
Des Moines 3
Grosseto 3
Guangzhou 3
Jinan 3
Lima region 3
London 3
Muizenberg 3
Portland 3
Redmond 3
Shanghai 3
Trumbull 3
Bangkok 2
Bielefeld 2
Bologna 2
Bouc-Bel-Air 2
Burgas 2
Cebu City 2
Changsha 2
Cincinnati 2
Filago 2
Fortaleza 2
Frankfurt am Main 2
Galdo 2
Horia 2
Indiana 2
Latina 2
Mannheim 2
Marano Di Napoli 2
Mexico City 2
Mezzago 2
Mountain View 2
Naples 2
Totale 3.035
Nome #
Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab 160
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN). a phase 3, randomised, double-blind, placebo-controlled, multicentre study 142
Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment. 123
HETERONYMOUS H REFLEX IN TEMPORAL MUSCLE AS SIGN OF HYPEREXCITABILITY IN ALS PATIENTS 119
Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study 118
Case report of adult- onset Allgrove Syndrome 112
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension 106
Effects of repetitive transcranial magnetic stimulation in a patient with fixation-off sensitivity 100
Is The Cutaneous Silent Period An Opiate-Sensitive Nociceptive Reflex? 95
A case of motor neuron involvement in Gaucher disease 95
Dysphagia in amyotrophic lateral sclerosis: impact on patient behavior, diet adaptation, and riluzole management 94
Assessing the neurophysiological effects of cannabinoids on spasticity in Multiple Sclerosis 92
Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation 91
Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings. 89
Modulation of human corticospinal excitability by paired associative stimulation in patients with amyotrophic lateral sclerosis and effects of Riluzole 88
Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis. a functional and anatomical study 88
Acute and chronic effects of ethanol on cortical excitability 87
Cutaneous silent period recordings in demyelinating and axonal polyneuropathies 85
Laryngeal sensitivity in patients with amyotrophic lateral sclerosis 85
Asymmetric responses to repetitive transcranial magnetic stimulation (rTMS) over the left and right primary motor cortex in a patient with lateralized progressive limb-kinetic apraxia 81
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis 80
A Novel Mutation in ABCA1 Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological Presentation 79
Creatine kinase and progression rate in amyotrophic lateral sclerosis 79
Attentional processing in bulbar- and spinal-onset amyotrophic lateral sclerosis: Insights from event-related potentials 78
Altered response to rTMS in patients with Alzheimer's disease 77
THE EFFECT OF H-COIL REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON PAINFUL DIABETIC NEUROPATHY: A RANDOMIZED PLACEBO-CONTROLLED CROSSOVER STUDY 75
Atypical case of diaphragmatic pseudo myoclonus 74
Cannabinoid-induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis 74
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study 74
Effects of visual deprivation on primary motor cortex excitability: a study on healthy subjects based on repetitive transcranial magnetic stimulation. 73
Effects of repetitive transcranial magnetic stimulation on spike-and-wave discharges 72
Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine 71
Differences in short-term primary motor cortex synaptic potentiation as assessed by repetitive transcranial magnetic stimulation in migraine patients with and without aura 69
Transcranial magnetic stimulation as a new tool to control pain perception 69
Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: A clinical and neurophysiological study 68
Attention influences the excitability of cortical motor areas in healthy humans 66
Belly dance syndrome due to spinal myoclonus 64
Synaptic potentiation induced by rTMS: effect of lidocaine infusion 64
Electrical and magnetic repetitive transcranial stimulation of the primary motor cortex in healthy subjects 64
Physiological characterization of human muscle acetylcholine receptors from ALS patients 64
Vitamina D in Amyotorphic Lateral Sclerosis 63
Predictive role of neurophysiological features on Bell’s palsy 61
Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis. 60
The Compound Muscle Action Potential as Neurophysiological Marker for Amyotrophic Lateral Sclerosis. 59
Influence of the corticospinal tract on the cutaneous silent period: A study in patients with pyramidal syndrome 58
Venlafaxine and bladder function 58
Consistent improvement with eculizumab across muscle groups in myasthenia gravis 57
Neurophysiology of the pelvic floor in clinical practice: a systematic literature review 53
Bilateral spike-and-wave dicharges in a hemi-deafferented cortex 52
Effects of transcranial magnetic stimulation on the H reflex and F wave in the hand muscles 49
Topiramate and cortical excitability in humans: A study with repetitive transcranial magnetic stimulation 49
Bladder filling inhibits somatic spinal motorneurones 49
Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study 43
Excitatory and inhibitory after-effects after repetitive magnetic transcranial stimulation (rTMS) in normal subjects 42
From touch to brain control: augmenting communication in persons with ALS 38
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 35
Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study 34
Effects of intermittent theta burst stimulation on cerebral blood flow and cerebral vasomotor reactivit 34
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2) 20
Totale 4.398
Categoria #
all - tutte 11.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.176


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020974 0 0 11 44 102 245 178 123 116 58 63 34
2020/2021417 38 51 56 22 19 32 9 22 73 50 29 16
2021/2022696 8 42 72 35 76 22 23 80 44 38 155 101
2022/2023767 114 204 50 74 68 61 20 69 45 18 35 9
2023/2024480 17 60 41 42 27 71 7 84 9 54 27 41
2024/2025152 28 124 0 0 0 0 0 0 0 0 0 0
Totale 4.398